On August 6, 2021 GT Biopharma, Inc. ("GT Biopharma" or the "Company") (NASDAQ: GTBP), a clinical stage immuno-oncology company focused on developing innovative therapeutics based on the Company’s proprietary natural killer (NK) cell engager (TriKE) protein biologic technology platform, reported that the management team will host a conference call to discuss second quarter 2021 financial results and general business updates on August 13, 2021 at 8:30 a.m. EST (Press release, GT Biopharma, AUG 6, 2021, https://ir.gtbiopharma.com/news/detail/230/gt-biopharma-to-host-conference-call-to-discuss-second-quarter-2021-results [SID1234586003]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

To join the call:

U.S. callers should dial 1-877-870-4263 and international callers should dial 1-412-317-0790.
All participants should ask to be connected to the GT Biopharma conference call.
The call will be available by visiting the "Presentations" page in the "News & Media" section of GT Biopharma’s website at www.gtbiopharma.com/news-media/presentations. A replay of the call will be archived for 30 days following the presentation.